Veracyte, Inc.
VCYT· Nasdaq
- Last sale
- Oct 1, 2026 · -3.78%
- Market cap
- $3.56B
- 80.39M shares
- Filings
- 1,024
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $517,145,000 | reported | |
| FY 2024 | 2024-12-31 | $445,764,000 | reported | |
| FY 2023 | 2023-12-31 | $361,051,000 | reported | |
| FY 2022 | 2022-12-31 | $296,536,000 | reported | |
| FY 2021 | 2021-12-31 | $219,514,000 | reported | |
| FY 2020 | 2020-12-31 | $117,483,000 | reported | |
| FY 2019 | 2019-12-31 | $120,368,000 | reported | |
| FY 2018 | 2018-12-31 | $92,008,000 | reported | |
| FY 2017 | 2017-12-31 | $71,953,000 | reported | |
| FY 2016 | 2016-12-31 | $65,085,000 | reported | |
| FY 2015 | 2015-12-31 | $49,503,000 | reported | |
| FY 2014 | 2014-12-31 | $38,190,000 | reported |
Veracyte, Inc. · CIK 1384101 · Engraved from SEC EDGAR
